Truls Østbye

American Journal of Public Health · 2000–2009

A researcher in the Science corpus: 4 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Whom Truls Østbye trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Peter Basch

Who trusts Truls Østbye overall

  1. Thomas Bodenheimer
  2. John D. Piette

Papers from Truls Østbye's perspective

Ordered by how strongly the researchers Truls Østbye trusts endorse each paper. Same corpus, a different order for every researcher.

  1. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. (Journal of the American Medical Association (JAMA))
  2. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. (Journal of the American Medical Association (JAMA))
  3. Quality of health care delivered to adults in the United States. (New England Journal of Medicine)
  4. Prevalence and trends in obesity among US adults, 1999-2000. (Journal of the American Medical Association (JAMA))
  5. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. (New England Journal of Medicine)
  6. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. (New England Journal of Medicine)
  7. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. (Journal of the American Medical Association (JAMA))
  8. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. (Journal of the American Medical Association (JAMA))
  9. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. (New England Journal of Medicine)
  10. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. (New England Journal of Medicine)

Their papers